000 | 00901 a2200253 4500 | ||
---|---|---|---|
005 | 20250517190151.0 | ||
264 | 0 | _c20181004 | |
008 | 201810s 0 0 eng d | ||
022 | _a1365-2133 | ||
024 | 7 |
_a10.1111/bjd.15947 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMurrell, D F | |
245 | 0 | 0 |
_aRituximab and short-course prednisone as the new gold standard for new-onset pemphigus vulgaris and pemphigus foliaceus. _h[electronic resource] |
260 |
_bThe British journal of dermatology _c11 2017 |
||
300 |
_a1143-1144 p. _bdigital |
||
500 | _aPublication Type: Editorial; Comment | ||
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPemphigus |
650 | 0 | 4 | _aPrednisone |
650 | 0 | 4 | _aRituximab |
700 | 1 | _aSprecher, E | |
773 | 0 |
_tThe British journal of dermatology _gvol. 177 _gno. 5 _gp. 1143-1144 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/bjd.15947 _zAvailable from publisher's website |
999 |
_c27842329 _d27842329 |